How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

32,043 results for

Hypertension Evaluation History

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives

Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02979197 Recruitment Status : Completed First Posted : December 1, 2016

2016 Clinical Trials

42. Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning (...) You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier

2016 Clinical Trials

43. An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record (...) Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal

2016 Clinical Trials

44. Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)

Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results (...) information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA) (OPTIMA) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators

2016 Clinical Trials

45. Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer (...) to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy The safety and scientific validity of this study

2016 Clinical Trials

46. Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany

Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02660463 Recruitment Status : Unknown Verified January 2016

2016 Clinical Trials

47. A Study to Evaluate Safety and Efficacy of the Redyâ„¢ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension

A Study to Evaluate Safety and Efficacy of the Redyâ„¢ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension A Study to Evaluate Safety and Efficacy of the Redy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Evaluate Safety and Efficacy of the Redy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier

2016 Clinical Trials

48. Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension

Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02885155 Recruitment Status : Completed First Posted : August 31, 2016 Last Update Posted : August 31, 2016 Sponsor: Central Hospital

2016 Clinical Trials

49. A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information (...) . Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does

2016 Clinical Trials

50. Hypertension Evaluation Labs

Hypertension Evaluation Labs Hypertension Evaluation Labs Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hypertension Evaluation Labs (...) Hypertension Evaluation Labs Aka: Hypertension Evaluation Labs , Hypertension Diagnostic Testing From Related Chapters II. Labs: General for All Patients ( or minimum) g lipid profile Non- g may be sufficient initially However, high g serum levels (with low ) may suggest Basic Metabolic Panel (Chem8, SMA7) g is preferred (esp. if non- g is abnormal) Consider primary if (even borderline low) With calculated (GFR) increased in , , renal parenchymal disease (BUN) III. Labs: Optional Studies (as indicated

2018 FP Notebook

51. Hypertension Evaluation Exam

Hypertension Evaluation Exam Hypertension Evaluation Exam Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hypertension Evaluation Exam (...) Hypertension Evaluation Exam Aka: Hypertension Evaluation Exam From Related Chapters II. Goals Identify end organ damage Identify signs Identify reversible exacerbating factors Document progression III. Exam: Vitals Consider arm to leg systolic BP measurements (difference >20 mmHg suggests ) Assess for Weight and Height or BMI (assess for ) IV. Exam: Head See increased in V. Exam: Neck exam s Neck vein exam VI. Exam: Chest signs Palpable intercostal pulses VII. Exam: Cardiovascular rhythm (decreased LV

2018 FP Notebook

52. Hypertension Evaluation

Evaluation Aka: Hypertension Evaluation , Secondary Hypertension From Related Chapters II. Epidemiology Secondary Hypertension accounts for 5-10% of overall In age 18 to 40 years old, accounts for 30% of III. Approach See Confirm See Confirm with at least 2-3 reliable readings over at least 2 separate visits Repeated manual readings in both arms with properly sized cuff Consider Identify associated risk factors See history See Sedentary lifestyle abuse Excessive emotional Stress Poor diet (high , low (...) Hypertension Evaluation Hypertension Evaluation Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hypertension Evaluation Hypertension

2018 FP Notebook

53. A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension

) months from screening date Laser surgery for glaucoma / ocular hypertension on one (1) or both eyes within the last six (6) months Past history of any incisional surgery for glaucoma at any time Past history of corneal refractive surgery Corneal abnormalities that would interfere with accurate IOP readings with an applanation tonometer Current participation in an investigational drug or device study or participation in such a study within 7 days of Screening Inability to adequately evaluate (...) A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study

2016 Clinical Trials

54. OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension

OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before

2016 Clinical Trials

55. Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease

role of genetic factors has long been hypothesised, due to the observation that a family history of hypertension appears to predict the development of nephropathy. 17 It has been suggested that a family history of hypertension could be the basis for more intensive antihypertensive therapy in patients with type 1 diabetes. The risk factor that has the strongest association with progression of diabetic nephropathy is hypertension. Prospective evaluation of 148 patients with type 1 diabetes who were (...) , independent of their blood pressure lowering effect, as shown in the Heart Outcomes Prevention Evaluation (HOPE) trial and the European trial on reduction of cardiac events with perindopril in stable coronary artery disease. 117,118 Whereas most guidelines favour the use of RAAS blockade as first-line treatment for people with diabetes, hypertension and CKD (the American Diabetes Association, the American Society of Hypertension, the International Society of Hypertension), 119,120 the European Society

2017 Association of British Clinical Diabetologists

56. CRACKCast E084 – Hypertension

CRACKCast E084 – Hypertension CRACKCast E084 - Hypertension - CanadiEM CRACKCast E084 – Hypertension In , by Adam Thomas June 8, 2017 This episode of CRACKCast covers Rosen’s chapter 84, Hypertension. Often thought to be a problem better handled by family physicians, hypertension is a frequent encounter in the ED where decision making between intervening and doing nothing is often the main hurdle. Shownotes – Rosen’s in Perspective HTN is common, and is on the rise in prevalence Definition (...) with asymptomatic elevated BP from those with symptomatic elevated BP (acute vasculopathy) Recent trends to shift away from cosmetic BP reduction, to focus on interventions based on actual clinical disease (e.g. end organ dysfunction). Hypertensive crisis, urgency, malignant HTN are now obsolete [1] Define the three classes of hypertension relevant to emergency medicine practice Hypertensive emergency: “acute target-organ dysfunction, manifesting with newly developed clinical sequelae or consequential

2017 CandiEM

57. Pharmacological Management of Hypertension

Pharmacological Management of Hypertension Pharmacological Management of Hypertension | National Guideline Clearinghouse success fail JUL Aug 12 2017 2018 2019 02 Oct 2017 - 13 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers (...) VA/DoD (2014) Pharmacological Therapy Initiation of Pharmacotherapy The Work Group recommends offering pharmacologic treatment for hypertensive patients 60 years and older with a SBP ≥160 mmHg. ( Strong for ) The Work Group suggests considering pharmacologic treatment using a shared decision-making model for hypertensive patients 60 years and older with SBP <160 mmHg. ( Weak for ) The Work Group suggests offering pharmacologic treatment to patients with a history of cerebrovascular disease

2017 National Guideline Clearinghouse (partial archive)

58. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians

the quality of evidence using the Agency for Healthcare Research and Quality system ( ). Population Adults aged 60 years or older with a diagnosis of hypertension were studied. Interventions Evaluated The interventions evaluated included treatment to higher (<150 mm Hg) versus lower (≤140 mm Hg) SBP targets. Comparators The comparator was less intensive BP treatment. Outcomes Evaluated outcomes included all-cause mortality; cardiac events (myocardial infarction and sudden cardiac death); morbidity (...) and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens 2005 18 1052 9 Bird AS , Blizard RA , Mann AH . Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. J Hypertens 1990 8 147 52 Margolis KL , Palermo L , Vittinghoff E , Evans GW , Atkinson HH , Hamilton BP . et al Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J

Full Text available with Trip Pro

2017 American College of Physicians

59. Evaluation of the Thoracic and Lumbar Spine in Blunt Trauma

Evaluation of the Thoracic and Lumbar Spine in Blunt Trauma Evaluation of the Thoracic and Lumbar Spine in Blunt Trauma | Emergency Medicine | Washington University in St. Louis Open Menu Back Close Menu Search for: Loading... Welcome Sections Education Fellowships Research Journal Club Events Open Search Vignette You’re working a shift at a level II trauma center in the community one rainy afternoon when EMS brings in Mr. Q a 62-year old man with hypertension and hyperlipidemia who (...) for evaluation of the thoracic and lumbar spine. At least one observational study from LA County/USC Medical Center ( ) suggested that physical exam alone performed poorly at evaluating for a “clinically significant” injury of the thoracic or lumbar spine, with with a sensitivity of 78.6%, specificity of 83.4%, LR+ of 4.73, and LR- of 0.26. A recent systematic review on this topic ( ) similarly found that aspects of the history and physical exam (when looked at independently) were inadequate at ruling

2019 Washington University Emergency Medicine Journal Club

60. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy

Article Outline Abstract We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2012. The new recommendations are: (1) use of home blood pressure monitoring to confirm a diagnosis of white coat syndrome; (2) mineralocorticoid receptor antagonists may be used in selected patients with hypertension and systolic heart failure; (3) a history of atrial fibrillation in patients with hypertension should not be a factor in deciding (...) of hypertension, ambulatory monitoring, and the use of echocardiography in hypertensive individuals are unchanged. Prevention and treatment New recommendations include: (1) aldosterone antagonists are recommended for hypertension and systolic heart failure in addition to the suggested therapy; (2) a history of atrial fibrillation (AF) in patients with hypertension should not be a factor in deciding to prescribe an angiotensin-receptor blocker (ARB) for the treatment of hypertension; (3) from a rereview

2012 CPG Infobase

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>